Monday, February 16, 2026

On a per enrollee basis, private insurance spending is growing faster than Medicare and Medicaid spending

China-origin assets accounted for an even larger share of big pharma licensing in Q1 2026

https://www.jpmorgan.com/content/dam/jpmorgan/documents/cb/insights/outlook/jpm-biopharma-deck-q1-2026.pdf